ORMP
Price
$2.18
Change
+$0.02 (+0.93%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
88.24M
41 days until earnings call
SRRK
Price
$35.99
Change
+$0.44 (+1.24%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
3.38B
34 days until earnings call
Interact to see
Advertisement

ORMP vs SRRK

Header iconORMP vs SRRK Comparison
Open Charts ORMP vs SRRKBanner chart's image
Oramed Pharmaceuticals
Price$2.18
Change+$0.02 (+0.93%)
Volume$170
Capitalization88.24M
Scholar Rock Holding
Price$35.99
Change+$0.44 (+1.24%)
Volume$140.95K
Capitalization3.38B
ORMP vs SRRK Comparison Chart in %
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. SRRK commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and SRRK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ORMP: $2.16 vs. SRRK: $35.55)
Brand notoriety: ORMP and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 64% vs. SRRK: 82%
Market capitalization -- ORMP: $88.24M vs. SRRK: $3.38B
ORMP [@Biotechnology] is valued at $88.24M. SRRK’s [@Biotechnology] market capitalization is $3.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 2 TA indicator(s) are bullish while SRRK’s TA Score has 6 bullish TA indicator(s).

  • ORMP’s TA Score: 2 bullish, 7 bearish.
  • SRRK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SRRK is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -0.92% price change this week, while SRRK (@Biotechnology) price change was -0.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.38B) has a higher market cap than ORMP($88.2M). ORMP YTD gains are higher at: -10.744 vs. SRRK (-17.746). ORMP has higher annual earnings (EBITDA): -21.53M vs. SRRK (-268.99M). SRRK has more cash in the bank: 364M vs. ORMP (131M). ORMP has less debt than SRRK: ORMP (301K) vs SRRK (63.1M). ORMP has higher revenues than SRRK: ORMP (2M) vs SRRK (0).
ORMPSRRKORMP / SRRK
Capitalization88.2M3.38B3%
EBITDA-21.53M-268.99M8%
Gain YTD-10.744-17.74661%
P/E Ratio20.91N/A-
Revenue2M0-
Total Cash131M364M36%
Total Debt301K63.1M0%
FUNDAMENTALS RATINGS
ORMP vs SRRK: Fundamental Ratings
ORMP
SRRK
OUTLOOK RATING
1..100
5867
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
8036
P/E GROWTH RATING
1..100
54100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (58) in the Pharmaceuticals Other industry is in the same range as SRRK (66) in the Biotechnology industry. This means that ORMP’s stock grew similarly to SRRK’s over the last 12 months.

SRRK's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that SRRK’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as SRRK (98) in the Biotechnology industry. This means that ORMP’s stock grew similarly to SRRK’s over the last 12 months.

SRRK's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for ORMP (80) in the Pharmaceuticals Other industry. This means that SRRK’s stock grew somewhat faster than ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for SRRK (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than SRRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPSRRK
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HACBY13.85N/A
N/A
Hachijuni Bank Ltd. (THE)
MGRUF4.23N/A
N/A
Morguard Real Estate Investment Trust
WPPGF7.43N/A
N/A
WPP PLC
IRRXU10.11N/A
N/A
Integrated Rail and Resources Acquisition Corp.
HYEX1.90-0.10
-5.00%
HEALTHY EXTRACTS INC.

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
+5.30%
ORMP - SRRK
42%
Loosely correlated
+2.86%
PLRX - SRRK
41%
Loosely correlated
+2.56%
VTGN - SRRK
40%
Loosely correlated
+1.49%
SNDX - SRRK
39%
Loosely correlated
+2.04%
ERAS - SRRK
38%
Loosely correlated
+6.62%
More